{
    "title": "Understanding giant cell sarcoma of the head and neck: A population-based study.",
    "doc_id": "34121252",
    "writer": "Sawhney R",
    "year": "2021",
    "summary": "BACKGROUND: Giant cell sarcomas (GCS) are rare head and neck neoplasms. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for all patients who have been diagnosed with GCS from 1973 to 2014. ...CONCLUSIONS: GCS presents most frequ â€¦",
    "abstract": "Background:\n        \n      \n      Giant cell sarcomas (GCS) are rare head and neck neoplasms.\n    \n\n\n          Methods:\n        \n      \n      The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for all patients who have been diagnosed with GCS from 1973 to 2014.\n    \n\n\n          Results:\n        \n      \n      Four hundred and forty cases of GCS of the head and neck were identified. The average age at diagnosis was 74.4 years, 86.8% were white, 82.5% were male, 70.7% were insured, and 88.2% lived in an urban metropolitan region. Connective tissue was the most frequent primary site (42.5%). The 5Y-DSS rate was 91.1%, while the 5Y-OS was 54.6% for all cases. Patients treated with surgery alone had the highest 5Y-DSS rate of 94.5. T-classification odds ratio was a significant predictor of survival accounting for confounding variables on multivariate analysis.\n    \n\n\n          Conclusions:\n        \n      \n      GCS presents most frequently in connective tissue of the head and neck with overall high probability of survival. The treatment of choice is surgery alone.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/34121252/"
}